section name header

Pronunciation

sef-oh-TAKS-eem

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: third generation cephalosporins

Indications

REMS


Action

  • Binds to the bacterial cell wall membrane, causing cell death.
Therapeutic effects:
  • Bactericidal action against susceptible bacteria.

Spectrum:

Pharmacokinetics

Absorption: Well absorbed following IM administration; IV administration results in complete bioavailability.

Distribution: Widely distributed. Crosses the placenta; enters breast milk in low concentrations. CSF penetration better than with first- and second-generation agents.

Metabolism/Excretion: Partly metabolized to active metabolite; 20–36% excreted unchanged in the urine.

Half-Life: Premature neonates: 5–6 hr; Full–term neonates: 2–3.4 hr; Children: 1.5 hr; Adults: 1–1.5 hr ( in renal impairment).

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
IMrapid0.5 hr4–12 hr
IVrapidend of infusion4–12 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Claforan